comparemela.com

Latest Breaking News On - Curetis gmbh - Page 17 : comparemela.com

2021 World Antimicrobial Resistance Diagnostic Market - Diagnostics Leading the Charge in Reducing the Threat Posed by Antimicrobial Resistance

2021 World Antimicrobial Resistance Diagnostic Market - Diagnostics Leading the Charge in Reducing the Threat Posed by Antimicrobial Resistance
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

OpGen Reports First Quarter 2021 Financial Results and Provides Business Update

OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections

Published: Apr 19, 2021 Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021 Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software within digital health and precision medicine platform at multiple healthcare institutions GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) OpGen, Inc.  (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health (“DOH”) to develop a state-of-the-art solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide is being extended beyond the second-year expansion phase by another six months through September 30, 2021. Having successfully achieved all of the milestones of the first and second year phases for the development of an infectious disease digital health and precision medicine platform that connects healthcare institutions

OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020

OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020 GAITHERSBURG, Md., March 11, 2021 (GLOBE NEWSWIRE) OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter and full year 2020 financial results after the close of the U.S. financial markets on Thursday, March 25, 2021. OpGen’s management team will host a live conference call and audio webcast at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide an update on business activities. Conference Call Details    13717232 Following the conclusion of the conference call, a replay will be available through April 8, 2021. The live, listen-only webcast of the conference call may also be accessed by visiting the Investors section of the Company’s website at www.opgen.com. A replay of the webcast will be available following the conclusion of the call and will be

OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of

Press release content from Globe Newswire. The AP news staff was not involved in its creation. OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of . OpGen, Inc.March 8, 2021 GMT Karolinska Institutet Study highlights Unyvero HPN demonstrating a higher diagnostic yield than bacterial culture, enabling rapid diagnosis of pathogens of concern in these patients High negative predictive value of 99.8% may allow for reduction in unnecessary antibiotic use and support antibiotic stewardship efforts Performance data, comprehensive coverage and turnaround time of less than 5 hours from sample to result of this panel provides clinicians earlier data to inform antimicrobial decisions, especially in critically ill COVID-19 patients during flu season

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.